M&A

M&A

Lupin to buy 5 drug brands from Italy's Menarini for Rs.101-Cr

Press Release   BSE Announcement  

Mumbai-headquartered drugmaker Lupin is to acquire five brands, along with their trademark rights, from Florence, Italy-based Menarini, for INR 101 crore. The brands span the therapeutic segments of gastroenterology, urology and anti-infectives. Lupin has been exclusively marketing these brands in India since July 2021 under a pact with A. Menarini India Pvt Ltd. The brands being acquired include Piclin (Picosulphate Sodium), Menoctyl (Otilonium Bromide), Sucramal O (Sucralfate + Oxetacaine), Pyridium (Phenazopyridine) and Distaclor (Cefaclor). The turnover of the acquired brands for FY23 was about INR 32.2 crore.